Well, good morning, everyone, and welcome to Cullinan Therapeutics Immunology Day. Today is an important milestone for Cullinan and also the way autoimmune diseases may be treated in the future. As ...
A new review published in Calcified Tissue International highlights major advances in understanding and preventing bone loss ...
Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE ® (tocilizumab-bavi) injection, for ...
Investigators evaluated the safety and efficacy of daraxonrasib compared to standard-of-care chemotherapy in patients with ...
In the grand scheme of things, an unforgiving pancreas cancer could kill a person in a few months, and managing some ...
Rheumatoid arthritis-associated interstitial lung disease (ILD) presents a paradox: it is common and a major cause of ...
The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.
In this qualitative study of patient experiences with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), participants described GLP-1 RA therapy functioning as a facilitator rather than ...
The European Alliance of Associations for Rheumatology - held its 2026 annual Congress in London, where gout was high on the ...
Background Shorter dual antiplatelet therapy (DAPT) regimens may offer a more favourable risk-benefit profile compared with longer treatment. The aim of this study was to determine the optimal ...
Objectives This study evaluated the associations between achieving treatment goals and patient-reported outcomes (PROs) and healthcare resource utilisation (HCRU) among patients with rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results